Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Integra LifeSciences Holdings Corporation (IART) Presents at Morgan Stanley 24th Annual Global Healt

PRINCETON, N.J., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasda

Integra LifeSciences Holdings is a turnaround story, maintaining a BUY rating after a strong 2Q26 ea

Integra (IART) reported earnings 30 days ago. What's next for the stock?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Integra's SurgiMend relaunch could support a broader 2027 recovery, but customer recapture and FDA a

Integra's steep valuation discount meets margin gains and cost savings, but modest growth, leverage

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Wells Fargo analyst Larry Biegelsen maintains Integra Lifesciences (NASDAQ:IART) with a Equal-Wei

Integra LifeSciences Holdings Corporation (IART) Q2 2026 Earnings Call Transcript

Breakout stocks BSET, AVAH and IART are trading near 52-week highs after passing technical screens.

While the top- and bottom-line numbers for Integra (IART) give a sense of how the business performed

Integra LifeSciences NASDAQ: IART reported second-quarter 2026 revenue of $419 million, up 0.8% on a

Integra LifeSciences (IART) came out with quarterly earnings of $0.56 per share, beating the Zacks C

Integra Lifesciences (NASDAQ:IART) is looking for Q3 Adj EPS of $0.53-$0.61 vs $0.56 analyst estimat

Integra Lifesciences (NASDAQ:IART) affirms FY2026 Adj EPS guidance from $2.40-$2.50 to $2.40-$2.50 v

Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.56 per share which beat the ana

PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq

UBS analyst Patrick Wood initiates coverage on Integra Lifesciences (NASDAQ:IART) with a Neutral

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Investor litigation firm [url="]Kaskela Law[/url] announces that it is investigating Integra LifeSci

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigati

Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (

Truist Securities analyst Ravi Misra maintains Integra Lifesciences (NASDAQ:IART) with a Hold and

Integra (IART) is at a 52-week high, but can investors hope for more gains in the future? We take a

BMO Capital analyst Vik Chopra initiates coverage on Integra Lifesciences (NASDAQ:IART) with a Ma

Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Neutral and

Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Sell and rai

Wells Fargo analyst Larry Biegelsen maintains Integra Lifesciences (NASDAQ:IART) with a Equal-Wei

Dow Jones up 200 points, Rockwell Automation shares rise 10.8% on strong earnings and raised guidanc

Integra Lifesciences (NASDAQ:IART) is looking for Q2 Adj EPS of $0.44-$0.52 vs $0.53 analyst estimat

Integra Lifesciences (NASDAQ:IART) raises FY2026 Adj EPS guidance from $2.30-$2.40 to $2.40-$2.50 vs

Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.54 per share which beat the ana

Truist Securities analyst Ravi Misra maintains Integra Lifesciences (NASDAQ:IART) with a Hold and

Top Wall Street analysts changed outlook on top names. See all rating changes at https://www.benzing

Wells Fargo analyst Vik Chopra maintains Integra Lifesciences (NASDAQ:IART) with a Equal-Weight a

Integra Lifesciences (NASDAQ:IART) is looking for Q1 Adj EPS of $0.37-$0.45 vs $0.48 analyst estimat

Integra Lifesciences (NASDAQ:IART) is looking for FY2026 Adj EPS of $2.30-$2.40 vs $2.35 analyst est

Integra Lifesciences (NASDAQ:IART) reported quarterly earnings of $0.83 per share which beat the ana

FDA warns of high-risk device issue with wound and burn care products by Integra LifeSciences, citin

https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-wound-and-bu

Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company

Truist Securities analyst Ravi Misra reiterates Integra Lifesciences (NASDAQ:IART) with a Hold an

Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Sell and low

JP Morgan analyst Robbie Marcus maintains Integra Lifesciences (NASDAQ:IART) with a Underweight a